Variant report
Variant | esv3340601 |
---|---|
Chromosome Location | chr1:192859679-192862977 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527618684 | chr1:192859751-192859752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547251105 | chr1:192859813-192859814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570117715 | chr1:192859872-192859873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532741134 | chr1:192859890-192859891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376038693 | chr1:192859895-192859896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150601834 | chr1:192859906-192859907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567033984 | chr1:192859914-192859915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs12140719 | chr1:192860043-192860044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143416736 | chr1:192860084-192860085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555193111 | chr1:192860137-192860138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1890974 | chr1:192860144-192860145 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs1231754 | chr1:192860152-192860153 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs35194837 | chr1:192860172-192860173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554477144 | chr1:192860251-192860252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146730948 | chr1:192860256-192860257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190008012 | chr1:192860279-192860280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556260124 | chr1:192860304-192860305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576524113 | chr1:192860345-192860346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541946745 | chr1:192860360-192860361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561927210 | chr1:192860365-192860366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527439826 | chr1:192860389-192860390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540950773 | chr1:192860457-192860458 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182571851 | chr1:192860463-192860464 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533044894 | chr1:192860471-192860472 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549777147 | chr1:192860515-192860516 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11587297 | chr1:192860565-192860566 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186482252 | chr1:192860572-192860573 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529025940 | chr1:192860573-192860574 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548763560 | chr1:192860576-192860577 | Weak transcription ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568691225 | chr1:192860615-192860616 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534356090 | chr1:192860688-192860689 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554391487 | chr1:192860689-192860690 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140274057 | chr1:192860700-192860701 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571187580 | chr1:192860745-192860746 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539739457 | chr1:192860755-192860756 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79582195 | chr1:192860771-192860772 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144044761 | chr1:192860860-192860861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs75527176 | chr1:192860869-192860870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369651971 | chr1:192860907-192860908 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539825841 | chr1:192860918-192860919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149043739 | chr1:192860919-192860920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540864816 | chr1:192861061-192861062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs67952856 | chr1:192861082-192861083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368528058 | chr1:192861093-192861094 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563917997 | chr1:192861204-192861205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577562943 | chr1:192861242-192861243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543343744 | chr1:192861271-192861272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376937814 | chr1:192861337-192861338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563306473 | chr1:192861351-192861352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528853781 | chr1:192861360-192861361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 21062444 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:192843800-192861800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr1:192857400-192860600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
3 | chr1:192858800-192860400 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
4 | chr1:192859200-192860600 | Enhancers | Rectal Smooth Muscle | rectum |
5 | chr1:192859400-192860600 | Enhancers | Stomach Smooth Muscle | stomach |
6 | chr1:192859400-192860800 | Enhancers | Colon Smooth Muscle | Colon |
7 | chr1:192860400-192860800 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin01 | Skin |
8 | chr1:192860400-192861200 | Enhancers | Duodenum Smooth Muscle | Duodenum |
9 | chr1:192860600-192860800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr1:192860600-192861800 | Weak transcription | Rectal Smooth Muscle | rectum |
11 | chr1:192860800-192861200 | Enhancers | Fetal Muscle Trunk | muscle |
12 | chr1:192860800-192862000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
13 | chr1:192860800-192862000 | Weak transcription | Colon Smooth Muscle | Colon |
14 | chr1:192860800-192863200 | Enhancers | HMEC | breast |
15 | chr1:192861800-192862600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr1:192861800-192862800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr1:192861800-192862800 | Enhancers | Rectal Smooth Muscle | rectum |
18 | chr1:192861800-192862800 | Enhancers | NHEK | skin |
19 | chr1:192861800-192863200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
20 | chr1:192862000-192862400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
21 | chr1:192862000-192863000 | Enhancers | Colon Smooth Muscle | Colon |
22 | chr1:192862800-192870800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |